Market closedNon-fractional
InspireMD/NSPR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About InspireMD
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Ticker
NSPR
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Tel Aviv, Israel
Employees
68
Website
www.inspiremd.com
InspireMD Metrics
BasicAdvanced
$74M
Market cap
-
P/E ratio
-$0.74
EPS
0.97
Beta
-
Dividend rate
Price and volume
Market cap
$74M
Beta
0.97
Financial strength
Current ratio
7.896
Quick ratio
7.304
Long term debt to equity
2.605
Total debt to equity
4.17
Management effectiveness
Return on assets (TTM)
-48.78%
Return on equity (TTM)
-93.55%
Valuation
Price to revenue (TTM)
14.173
Price to book
1.99
Price to tangible book (TTM)
1.99
Price to free cash flow (TTM)
-5.35
Growth
Revenue change (TTM)
23.91%
Earnings per share change (TTM)
-67.88%
3-year revenue growth (CAGR)
38.14%
3-year earnings per share growth (CAGR)
-42.93%
What the Analysts think about InspireMD
Analyst Ratings
Majority rating from 1 analysts.
InspireMD Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.5M
-11.76%
Net income
-$7M
29.63%
Profit margin
-466.66%
46.91%
InspireMD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.25
-$0.16
-$0.17
-$0.22
-
Expected
-$0.32
-$0.16
-$0.20
-$0.16
-$0.19
Surprise
-20.00%
-3.23%
-17.95%
40.00%
-
InspireMD News
AllArticlesVideos
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
GlobeNewsWire·2 months ago
InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for InspireMD stock?
InspireMD (NSPR) has a market cap of $74M as of July 27, 2024.
What is the P/E ratio for InspireMD stock?
The price to earnings (P/E) ratio for InspireMD (NSPR) stock is 0 as of July 27, 2024.
Does InspireMD stock pay dividends?
No, InspireMD (NSPR) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next InspireMD dividend payment date?
InspireMD (NSPR) stock does not pay dividends to its shareholders.
What is the beta indicator for InspireMD?
InspireMD (NSPR) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell InspireMD stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.